ReviewBiomolecules2025
Biochar Utilization in Antimicrobial, Anticancer, and Biosensing Applications: A Review.
Review in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Click-Functionalized Biochar as a Spacer-Engineered Interface for Electrochemical Biosensing.ACS omega · 2026Article
- Sustainable valorization of citrus pomace waste: biochar production and in vitro bioactivities.Veterinary research communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Biochar, a carbonaceous material derived from biomass, has garnered significant attention for its biomedical applications due to its unique physicochemical properties. Recent advances in functionalized and composite biochar materials have enabled their use in antibacterial and anticancer treatments, as well as biosensing technologies. This review highlights recent advances in the use of biochar for antimicrobial, anticancer, and biosensing applications. Derived from plant-, marine-, or animal-based biomass through pyrolysis, biochar can be functionalized with silver nanoparticles, metal oxides, or polymers to enhance its antimicrobial activity. In anticancer research, biochar demonstrates the ability to inhibit cancer cell proliferation, modulate the cell cycle, and deliver targeted therapeutics, showing selective cytotoxicity against specific cancer cell types. Furthermore, biochar-based biosensors, when integrated with biomolecules such as enzymes, DNA, or antibodies, exhibit high sensitivity and specificity, making them suitable for precise disease diagnostics. These findings suggest that biochar holds significant potential as a sustainable biomedical material, offering alternatives to conventional antibiotics, supporting cancer therapy, and enabling sensitive biosensing platforms. Future functionalization strategies may further facilitate its clinical translation and practical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.